Jane Street’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.9M | Buy |
122,946
+111,700
| +993% | +$52.1M | 0.01% | 990 |
|
|
2025
Q4 | $5.1M | Sell |
11,246
-237,021
| -95% | -$102M | ﹤0.01% | 3197 |
|
|
2025
Q3 | $97.2M | Buy |
+248,267
| New | +$104M | 0.01% | 611 |
|
|
2025
Q2 | – | Sell |
-15,008
| Closed | -$6.92M | – | 11028 |
|
|
2025
Q1 | $7.28M | Buy |
15,008
+454
| +3% | +$212K | ﹤0.01% | 2393 |
|
|
2024
Q4 | $5.86M | Sell |
14,554
-39,638
| -73% | -$18.4M | ﹤0.01% | 2466 |
|
|
2024
Q3 | $25.2M | Sell |
54,192
-249,474
| -82% | -$120M | 0.01% | 1070 |
|
|
2024
Q2 | $142M | Buy |
303,666
+161,058
| +113% | +$69.9M | 0.03% | 286 |
|
|
2024
Q1 | $59.6M | Sell |
142,608
-31,151
| -18% | -$13.2M | 0.01% | 548 |
|
|
2023
Q4 | $70.7M | Buy |
173,759
+113,416
| +188% | +$41.9M | 0.02% | 528 |
|
|
2023
Q3 | $21M | Buy |
60,343
+31,869
| +112% | +$11.1M | 0.01% | 1061 |
|
|
2023
Q2 | $10M | Buy |
28,474
+6,735
| +31% | +$2.27M | ﹤0.01% | 1898 |
|
|
2023
Q1 | $6.85M | Sell |
21,739
-1,290
| -6% | -$387K | ﹤0.01% | 2045 |
|
|
2022
Q4 | $6.65M | Sell |
23,029
-10,017
| -30% | -$3.05M | ﹤0.01% | 2115 |
|
|
2022
Q3 | $9.57M | Buy |
33,046
+10,370
| +46% | +$2.98M | ﹤0.01% | 1741 |
|
|
2022
Q2 | $6.39M | Buy |
22,676
+5,752
| +34% | +$1.54M | ﹤0.01% | 2311 |
|
|
2022
Q1 | $4.42M | Sell |
16,924
-49,144
| -74% | -$11.7M | ﹤0.01% | 3247 |
|
|
2021
Q4 | $14.5M | Sell |
66,068
-69,179
| -51% | -$13.5M | ﹤0.01% | 1474 |
|
|
2021
Q3 | $24.5M | Sell |
135,247
-39,047
| -22% | -$7.62M | 0.01% | 1000 |
|
|
2021
Q2 | $35.1M | Buy |
174,294
+63,114
| +57% | +$13.2M | 0.01% | 721 |
|
|
2021
Q1 | $23.9M | Buy |
111,180
+8,347
| +8% | +$1.83M | 0.01% | 842 |
|
|
2020
Q4 | $24.3M | Buy |
102,833
+50,900
| +98% | +$11.7M | 0.01% | 758 |
|
|
2020
Q3 | $14.1M | Buy |
51,933
+40,423
| +351% | +$11.2M | 0.01% | 972 |
|
|
2020
Q2 | $3.34M | Sell |
11,510
-3,811
| -25% | -$1.03M | ﹤0.01% | 2353 |
|
|
2020
Q1 | $3.65M | Buy |
15,321
+6,495
| +74% | +$1.49M | ﹤0.01% | 1438 |
|
|
2019
Q4 | $1.93M | Sell |
8,826
-5,392
| -38% | -$1.09M | ﹤0.01% | 1979 |
|
|
2019
Q3 | $2.41M | Buy |
14,218
+3,697
| +35% | +$654K | ﹤0.01% | 1602 |
|
|
2019
Q2 | $1.93M | Sell |
10,521
-3,507
| -25% | -$613K | ﹤0.01% | 1909 |
|
|
2019
Q1 | $2.58M | Buy |
14,028
+7,785
| +125% | +$1.44M | ﹤0.01% | 1752 |
|
|
2018
Q4 | $1.03M | Sell |
6,243
-30,459
| -83% | -$5.28M | ﹤0.01% | 2505 |
|
|
2018
Q3 | $7.07M | Sell |
36,702
-17,580
| -32% | -$3.13M | 0.01% | 813 |
|
|
2018
Q2 | $9.23M | Buy |
54,282
+33,885
| +166% | +$5.25M | 0.02% | 649 |
|
|
2018
Q1 | $3.33M | Buy |
20,397
+14,581
| +251% | +$2.38M | 0.01% | 1312 |
|
|
2017
Q4 | $872K | Sell |
5,816
-6,439
| -53% | -$953K | ﹤0.01% | 2505 |
|
|
2017
Q3 | $1.86M | Sell |
12,255
-10,915
| -47% | -$1.64M | 0.01% | 1664 |
|
|
2017
Q2 | $2.99M | Sell |
23,170
-1,536
| -6% | -$185K | 0.01% | 1133 |
|
|
2017
Q1 | $2.7M | Sell |
24,706
-43,822
| -64% | -$3.86M | 0.01% | 1112 |
|
|
2016
Q4 | $5.05M | Buy |
68,528
+62,217
| +986% | +$5.06M | 0.02% | 660 |
|
|
2016
Q3 | $550K | Sell |
6,311
-9,089
| -59% | -$859K | ﹤0.01% | 2668 |
|
|
2016
Q2 | $1.32M | Sell |
15,400
-11,617
| -43% | -$1M | 0.01% | 1680 |
|
|
2016
Q1 | $2.15M | Sell |
27,017
-1,752
| -6% | -$158K | 0.01% | 1116 |
|
|
2015
Q4 | $3.62M | Buy |
28,769
+6,662
| +30% | +$804K | 0.02% | 660 |
|
|
2015
Q3 | $2.3M | Sell |
22,107
-24,139
| -52% | -$3.1M | 0.01% | 868 |
|
|
2015
Q2 | $5.71M | Buy |
46,246
+39,221
| +558% | +$4.94M | 0.04% | 408 |
|
|
2015
Q1 | $829K | Sell |
7,025
-790
| -10% | -$94.7K | 0.01% | 1540 |
|
|
2014
Q4 | $928K | Buy |
7,815
+6,032
| +338% | +$679K | 0.01% | 1078 |
|
|
2014
Q3 | $200K | Sell |
1,783
-9,239
| -84% | -$880K | ﹤0.01% | 2230 |
|
|
2014
Q2 | $1.04M | Sell |
11,022
-1,010
| -8% | -$70.8K | 0.01% | 883 |
|
|
2014
Q1 | $851K | Buy |
+12,032
| New | +$953K | 0.01% | 1090 |
|
|
2013
Q3 | – | Sell |
-12,609
| Closed | -$1.01M | – | 3164 |
|
|
2013
Q2 | $1.01M | Buy |
+12,609
| New | +$929K | 0.02% | 907 |
|
Other funds holding VRTX
VCM
VPM
Jane Street's VRTX Position: Q1 2026 in Review
Jane Street increased its Vertex Pharmaceuticals (VRTX) stake by 993% in Q1 2026, buying an estimated $52.1M and bringing the position to 122,946 shares worth $54.9M. The position accounts for 0.01% of the portfolio, ranked #990.
Jane Street first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $142M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Jane Street held 122,946 shares of Vertex Pharmaceuticals worth $54.9M as of Q1 2026.
- Jane Street bought 111,700 Vertex Pharmaceuticals shares in Q1 2026, an estimated $52.1M.
- Vertex Pharmaceuticals made up 0.01% of Jane Street's portfolio in Q1 2026, its #990 holding.
- Jane Street first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Jane Street's Vertex Pharmaceuticals position peaked at $142M in Q2 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.